Related Articles
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients
The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
EGFRvIII mutation in lung cancer correlates with increased EGFR copy number
Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab